The Nuclear Receptor Rev-erbα Regulates Adipose Tissue-specific FGF21 Signaling*

FGF21 is an atypical member of the FGF family that functions as a hormone to regulate carbohydrate and lipid metabolism. Here we demonstrate that the actions of FGF21 in mouse adipose tissue, but not in liver, are modulated by the nuclear receptor Rev-erbα, a potent transcriptional repressor. Interrogation of genes induced in the absence of Rev-erbα for Rev-erbα-binding sites identified βKlotho, an essential coreceptor for FGF21, as a direct target gene of Rev-erbα in white adipose tissue but not liver. Rev-erbα ablation led to the robust elevated expression of βKlotho. Consequently, the effects of FGF21 were markedly enhanced in the white adipose tissue of mice lacking Rev-erbα. A major Rev-erbα-controlled enhancer at the Klb locus was also bound by the adipocytic transcription factor peroxisome proliferator-activated receptor (PPAR) γ, which regulates its activity in the opposite direction. These findings establish Rev-erbα as a specific modulator of FGF21 signaling in adipose tissue.

[1]  Kyoung-Jae Won,et al.  Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo , 2015, Cell.

[2]  M. Lazar,et al.  Discrete functions of nuclear receptor Rev-erbα couple metabolism to the clock , 2015, Science.

[3]  Kyoung-Jae Won,et al.  PRDM16 binds MED1 and controls chromatin architecture to determine a brown fat transcriptional program , 2015, Genes & development.

[4]  Ankur Roy,et al.  Circadian Enhancers Coordinate Multiple Phases of Rhythmic Gene Transcription In Vivo , 2014, Cell.

[5]  M. Lazar,et al.  Nutrient Sensing Nuclear Receptors Coordinate Autophagy , 2014, Nature.

[6]  Kyoung-Jae Won,et al.  Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers , 2014, Genes & development.

[7]  M. Lazar,et al.  Behavioral changes and dopaminergic dysregulation in mice lacking the nuclear receptor Rev-erbα. , 2014, Molecular endocrinology.

[8]  A. Adams,et al.  Inventing new medicines: The FGF21 story☆ , 2013, Molecular metabolism.

[9]  M. Lazar,et al.  The Nuclear Receptor Rev-erbα Controls Circadian Thermogenic Plasticity , 2013, Nature.

[10]  A. Adams,et al.  Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones. , 2013, Molecular metabolism.

[11]  C. Danko,et al.  Enhancer transcripts mark active estrogen receptor binding sites , 2013, Genome research.

[12]  C. Glass,et al.  Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription , 2013, Nature.

[13]  J. Eeckhoute,et al.  Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy , 2013, Nature Medicine.

[14]  R. Gimeno,et al.  The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. , 2013, Molecular metabolism.

[15]  A. Adams,et al.  FGF21 Requires βklotho to Act In Vivo , 2012, PloS one.

[16]  S. Kliewer,et al.  βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. , 2012, Cell metabolism.

[17]  Jing Xu,et al.  FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice , 2012, PloS one.

[18]  P. Pévet,et al.  The nuclear receptor REV‐ERBα is required for the daily balance of carbohydrate and lipid metabolism , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Logan J Everett,et al.  Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. , 2012, Genes & development.

[20]  S. Kliewer,et al.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. , 2012, Genes & development.

[21]  B. Spiegelman,et al.  FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. , 2012, Genes & development.

[22]  A. Loudon,et al.  The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines , 2011, Proceedings of the National Academy of Sciences.

[23]  Jun Li,et al.  Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1 , 2011, Science Translational Medicine.

[24]  Clifford A. Meyer,et al.  Cistrome: an integrative platform for transcriptional regulation studies , 2011, Genome Biology.

[25]  Albin Sandelin,et al.  Cross species comparison of C/EBPα and PPARγ profiles in mouse and human adipocytes reveals interdependent retention of binding sites , 2011, BMC Genomics.

[26]  Tao Liu,et al.  A Circadian Rhythm Orchestrated by Histone Deacetylase 3 Controls Hepatic Lipid Metabolism , 2011, Science.

[27]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[28]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[29]  R. Young,et al.  Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.

[30]  S. Kliewer,et al.  Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. , 2010, Molecular endocrinology.

[31]  M. Lazar,et al.  Transcriptional Repressor E4-binding Protein 4 (E4BP4) Regulates Metabolic Hormone Fibroblast Growth Factor 21 (FGF21) during Circadian Cycles and Feeding* , 2010, The Journal of Biological Chemistry.

[32]  Hélène Duez,et al.  Nuclear receptors linking circadian rhythms and cardiometabolic control. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[33]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[34]  G. Kreiman,et al.  Widespread transcription at neuronal activity-regulated enhancers , 2010, Nature.

[35]  I. Lemieux,et al.  Obesity, Inflammation, and Cardiovascular Risk , 2010, Clinical pharmacology and therapeutics.

[36]  L. Solt,et al.  Regulation of FGF21 Expression and Secretion by Retinoic Acid Receptor-related Orphan Receptor α* , 2010, The Journal of Biological Chemistry.

[37]  B. Spiegelman,et al.  PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis , 2009, Proceedings of the National Academy of Sciences.

[38]  Ueli Schibler,et al.  REV-ERBα Participates in Circadian SREBP Signaling and Bile Acid Homeostasis , 2009, PLoS biology.

[39]  D. Wasserman,et al.  Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. , 2009, Endocrinology.

[40]  J. Schug,et al.  Re-expression of GATA2 Cooperates with Peroxisome Proliferator-activated Receptor-γ Depletion to Revert the Adipocyte Phenotype* , 2009, Journal of Biological Chemistry.

[41]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[42]  Leighton J. Core,et al.  Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters , 2008, Science.

[43]  D. Moller,et al.  Fibroblast growth factor 21 corrects obesity in mice. , 2008, Endocrinology.

[44]  M. Czech,et al.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[45]  J. D. Dunbar,et al.  FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlotho , 2008, Journal of cellular physiology.

[46]  Masashi Suzuki,et al.  betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. , 2008, Molecular endocrinology.

[47]  M. Lazar,et al.  Mechanisms of obesity-associated insulin resistance: many choices on the menu. , 2007, Genes & development.

[48]  W. Wahli,et al.  Fat poetry: a kingdom for PPARγ , 2007, Cell Research.

[49]  K. Rosenblatt,et al.  βKlotho is required for metabolic activity of fibroblast growth factor 21 , 2007, Proceedings of the National Academy of Sciences.

[50]  Yun-Fei Chen,et al.  The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. , 2007, Endocrinology.

[51]  F. Mehrbod,et al.  Molecular determinants of FGF‐21 activity—synergy and cross‐talk with PPARγ signaling , 2007, Journal of cellular physiology.

[52]  J. Gromada,et al.  Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways , 2006, Diabetes.

[53]  J. Gromada,et al.  FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.

[54]  Vincent Laudet,et al.  Principles for modulation of the nuclear receptor superfamily , 2004, Nature Reviews Drug Discovery.

[55]  M. Lazar,et al.  The N-CoR/Histone Deacetylase 3 Complex Is Required for Repression by Thyroid Hormone Receptor , 2003, Molecular and Cellular Biology.

[56]  Ueli Schibler,et al.  The Orphan Nuclear Receptor REV-ERBα Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian Oscillator , 2002, Cell.

[57]  C. Glass,et al.  A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains , 1996, Molecular and cellular biology.

[58]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[59]  M. Lazar,et al.  direct repeat . represses transcription as a dimer on a novel The monomer-binding orphan receptor RevErb , 1995 .

[60]  B. Spiegelman,et al.  Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.

[61]  M. Lazar,et al.  Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. , 1994, Endocrinology.

[62]  B. Spiegelman,et al.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.

[63]  R. Evans,et al.  Nuclear receptors, metabolism, and the circadian clock. , 2007, Cold Spring Harbor symposia on quantitative biology.